 | Up a level |
Rowe, FJ 
ORCID: 0000-0001-9210-9131, Conroy, EJ ORCID: 0000-0003-4858-727X, Bedson, E, Cwiklinski, E, Drummond, A, Garcia-Finana, M ORCID: 0000-0003-4939-0575, Howard, C, Pollock, A, Shipman, T, Dodridge, C et al (show 5 more authors)
(2017)
Choice of outcome measures for the VISION pilot trial of interventions for hemianopia.
ACTA NEUROLOGICA SCANDINAVICA, 136 (5).
pp. 551-553.
Hughes, David, Bonnett, LJ ORCID: 0000-0002-6981-9212, Czanner, G, Arnost, Komarek, Marson, anthony ORCID: 0000-0002-6861-8806 and Garcia-Finana, M ORCID: 0000-0003-4939-0575
(2018)
Identification of patients who will not achieve seizure remission within 5 years on AEDs.
Neurology, 91 (22).
e2035-e2044.
Harding, SP ORCID: 0000-0003-4676-1158, Eleuteri, A ORCID: 0000-0003-0718-6672, Fisher, AC, Broadbent, DM, Garcia-Finana, M ORCID: 0000-0003-4939-0575, Cheyne, CP, Wang, A, Stratton, IM, Gabbay, M ORCID: 0000-0002-0126-8485 and Seddon, D
(2017)
Individualised variable interval risk-based screening for sight threatening diabetic retinopathy – the Liverpool Risk Calculation Engine.
Diabetologia, 60 (11).
pp. 2174-2182.
Lythgoe, DT ORCID: 0000-0002-4682-772X, Garcia-Finana, M ORCID: 0000-0003-4939-0575 and Cox, TF
(2018)
Latent class modelling with a time-to-event distal outcome: A comparison of one, two and three-step approaches.
Structural Equation Modeling: A Multidisciplinary Journal, 26 (1).
pp. 51-65.
Garcia-Finana, M ORCID: 0000-0003-4939-0575, Hughes, David ORCID: 0000-0002-1287-9994, Cheyne, CP, Broadbent, DM, wang, , Wang, amu, komarek, Arnost, Stratton, Irene M, Mobayen-Rahni, Mehrdad, Alshukri, AS ORCID: 0000-0003-0852-2068 et al (show 2 more authors)
(2019)
Personalized risk‐based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules.
Diabetes, Obesity and Metabolism, 21 (3).
pp. 560-568.
Pushpakom, SP ORCID: 0000-0002-6682-4235, Kolamunnage-Dona, Ruwanthi ORCID: 0000-0003-3886-6208, Taylor, Claire, Foster, Terry ORCID: 0000-0001-7725-7902, Spowart, Cath, Garcia-Finana, M ORCID: 0000-0003-4939-0575, Kemp, GJ ORCID: 0000-0002-8324-9666, Jaki, Thomas, Khoo, SH ORCID: 0000-0002-2769-0967, Williamson, Paula ORCID: 0000-0001-9802-6636 et al (show 1 more authors)
(2020)
TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy.
Clinical Infectious Diseases, 70 (10).
pp. 2062-2072.